Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1720983
Disease: Channelopathies
Channelopathies
0.010 AlteredExpression disease BEFREE Although aberrant expression of TREK-1 is implicated in cognitive impairment, the cellular and functional mechanism underlying this channelopathy is poorly understood. 31728930 2020
CUI: C0006111
Disease: Brain Diseases
Brain Diseases
0.010 AlteredExpression group BEFREE TWIK-related potassium channel-1 (TREK-1) is broadly expressed in the brain and involved in diverse brain diseases, such as seizures, ischemia, and depression. 31771312 2019
CUI: C0574785
Disease: Lower Urinary Tract Symptoms
Lower Urinary Tract Symptoms
0.010 GeneticVariation phenotype BEFREE The aim of this study was to compare single nucleotide polymorphisms (SNPs) in TREK-1 channel between patients with LUTS and healthy donors. 30350878 2019
CUI: C0796074
Disease: MOHR-TRANEBJAERG SYNDROME
MOHR-TRANEBJAERG SYNDROME
0.010 AlteredExpression disease BEFREE However, an appropriate length MTS (MethaneThioSulfonate) cross-linking reagent (MTS14) restricted the activation of TREK-1_A286C channels by repeated application of FFA. 31455781 2019
CUI: C0856742
Disease: Post MI
Post MI
0.010 Biomarker phenotype BEFREE Our data suggest that TREK-1 has a protective effect against I/R-induced injury and influences the post-MI remodeling processes by regulating membrane potential and maintaining intracellular Ca<sup>2+</sup> homeostasis. 31511966 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.010 Biomarker disease BEFREE Moreover, ROC curves indicated that KCNK2, KCNK9, KCNK15, and KCNK17 levels could be used as a diagnostic biomarker for HCC. 31581133 2019
CUI: C2938940
Disease: Post stroke depression
Post stroke depression
0.010 Biomarker disease BEFREE This work reveals the first evidence that the modulation of TREK-1 channels in the early and chronic phases of stroke as well as the stimulation of brain plasticity by mini-spadin could play a key role in its brain protective effects against stroke and its deleterious consequences such as PSD. 31325429 2019
CUI: C3266262
Disease: Multiple Chronic Conditions
Multiple Chronic Conditions
0.010 Biomarker disease BEFREE TREK-1 is multi-regulated by a variety of physical and chemical stimuli which makes it a very promising and challenging target in the treatment of several pathologies. 31031627 2019
CUI: C0005694
Disease: Bladder neck obstruction
Bladder neck obstruction
0.010 AlteredExpression disease BEFREE Increased Expression of TREK-1 K+ Channel in the Dorsal Root Ganglion of Rats with Detrusor Overactivity After Partial Bladder Outlet Obstruction. 29462125 2018
CUI: C0027796
Disease: Neuralgia
Neuralgia
0.010 AlteredExpression phenotype BEFREE Our findings suggested that miR-183-5P participated in the regulation of CCI-induced neuropathic pain through inhibiting the expression of TREK-1. 29736614 2018
CUI: C1397307
Disease: Cardiac fibrosis
Cardiac fibrosis
0.010 Biomarker disease BEFREE The absence of pressure overload-induced dysfunction in TREK-1-KO mice was associated with diminished cardiac fibrosis and reduced activation of JNK in cardiomyocytes and fibroblasts. 30153110 2018
CUI: C2215101
Disease: Acute cerebral ischemia
Acute cerebral ischemia
0.010 Biomarker disease BEFREE Two-pore domain potassium channel TREK-1 was known to play an important role in neuroprotection, especially in acute cerebral ischemia. 29438799 2018
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.010 AlteredExpression disease BEFREE Gene transfer effectively increased TREK-1 protein levels and attenuated atrial effective refractory period prolongation in the porcine AF model. 28005193 2017
CUI: C0042514
Disease: Tachycardia, Ventricular
Tachycardia, Ventricular
0.010 GeneticVariation disease BEFREE Sodium permeable and "hypersensitive" TREK-1 channels cause ventricular tachycardia. 28242754 2017
CUI: C0542476
Disease: Forgetful
Forgetful
0.010 Biomarker phenotype BEFREE Taken together, our data demonstrate that inhibition of TREK-1 protects mice from cognitive impairment induced by anesthesia and TREK-1 is a potential therapeutic target against memory impairment induced by volatile anesthetics. 29042297 2017
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.010 Biomarker disease BEFREE pH-sensitive K(+) channel TREK-1 is a novel target in pancreatic cancer. 27443495 2016
CUI: C0346647
Disease: Malignant neoplasm of pancreas
Malignant neoplasm of pancreas
0.010 Biomarker disease BEFREE pH-sensitive K(+) channel TREK-1 is a novel target in pancreatic cancer. 27443495 2016
CUI: C0752130
Disease: Spinal Cord Ischemia
Spinal Cord Ischemia
0.010 Biomarker disease BEFREE Recent literature suggests lactate to be neuroprotective and TREK1 knockout mice show an increased sensitivity to brain and spinal cord ischaemia; however, the connecting link between the two is missing. 26445100 2016
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
0.010 Biomarker disease BEFREE TREK-1 may therefore be a promising novel target for PDAC therapy. 27443495 2016
CUI: C2607914
Disease: Allergic rhinitis (disorder)
Allergic rhinitis (disorder)
0.010 AlteredExpression disease BEFREE Regulation of Trek1 expression in nasal mucosa with allergic rhinitis by specific immunotherapy. 25529528 2015
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.010 Biomarker disease BEFREE These findings demonstrate that TREK-M can silence hyperexcitable neurons in the brain of epileptic rats and treat acute seizures. 24299204 2014
CUI: C0038220
Disease: Status Epilepticus
Status Epilepticus
0.010 Biomarker disease BEFREE To test if adenoassociated viral (AAV) delivery of TREK-M could reduce the duration of status epilepticus and reduce neuronal death induced by lithium-pilocarpine administration. 24299204 2014
CUI: C0740391
Disease: Middle Cerebral Artery Occlusion
Middle Cerebral Artery Occlusion
0.010 AlteredExpression disease BEFREE Rats that were preconditioned with sevoflurane were subjected to middle cerebral artery occlusion (MCAO), and the expression of TREK-1 protein and mRNA was analysed. 24154701 2014
CUI: C0002736
Disease: Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
0.010 Biomarker disease BEFREE The severity of EAE was attenuated in mice given the amyotrophic lateral sclerosis drug riluzole or fed a diet enriched with linseed oil (which contains the TREK-1 activating omega-3 fatty acid α-linolenic acid). 23933981 2013
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.010 Biomarker group BEFREE The K2P channel blockers methanandamide, lidocaine, zinc and curcumin had antiproliferative effects (P < 0.01) in an endometrial epithelial cancer cell line indicating a role for TASK and TREK-1 channels in proliferation. 23305490 2013